Low Prevalence of Cervical Cancer Screening Among HIV-Positive Women in Catalonia (Spain)
1Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Institut Català d’Oncologia (ICO), Agència Salut Pública de Catalunya (ASPC), Generalitat de Catalunya, Badalona, Spain
3Departament de Pediatria, d’Obstetrícia i Ginecologia i de Medicina Preventiva i de Salut Pública, Facultat de Medicina, Universitat Autònoma de Barcelona (UAB), Bellaterra (Cerdanyola del Vallès), Spain
- *Corresponding Author:
- Stuardo Valeria
Centre d’Estudis Epidemiològics sobre les Infeccions de
Transmissió Sexual i Sida de Catalunya (CEEISCAT)
Institut Català d’Oncologia (ICO)
Agència Salut Pública de Catalunya (ASPC)
Generalitat de Catalunya, Badalona, Spain
E-mail id: [email protected]
Received Date: April 04, 2013; Accepted Date: May 17, 2013; Published Date: May 21, 2013
Citation: Valeria S, Cristina A, Jordi C (2013) Low Prevalence of Cervical Cancer Screening Among HIV-Positive Women in Catalonia (Spain). J AIDS Clinic Res S3:004. doi:10.4172/2155-6113.S3-004
Copyright: © 2013 Valeria S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
There is evidence that HIV-positive women in Catalonia are at high risk for cervical cancer and have a high prevalence of oncogenic genotypes. Catalonia’s screening protocol recommends that HIV-positive women undergo Pap smear at least annually, and more frequently depending on CD4 count. The objective of the present study is to describe the cervical cancer screening among HIV-positive women in Catalonia, with an emphasis on screening coverage. This study included 479 HIV-positive women from the PISCIS cohort. Participants completed a clinicalepidemiological survey that included sociodemographic, behavioral, clinical, and screening history variables. All patients also underwent a gynecological exam, including endocervical sampling for conventional or liquid cytology (Papanicolau). 50.6% of the women reported annual PAP screenings; 11% had never had a Pap smear; and screening coverage for the last two-year was only 60.0%. The finding of low screening coverage is consistent with the high prevalence of cervical cancer in HIV-positive women in Catalonia. It is important to educate both medical professionals and HIV-positive women on the consequences of failure to screen for cervical cancer, diagnostic techniques to detect asymptomatic HPV, and methods of primary prevention.